You searched for "tear"
Animal antics for children with vision impairment
Nine families with children with vision impairment got up to some animal antics at a mini zoo in Perth, thanks to the charity RNIB.Crisis Collection Day sees volunteers’ success
Crisis at Christmas collection day saw 130 pairs of specs lined up to be dispensed to very grateful Londoners experiencing homelessness. Ranging in powers from +5D to -15.25D, the dispensing day brought together volunteers who have worked to provide eyecare...How to nearly (but not quite) get into ST1 ophthalmology training – some reflections
Ophthalmology is often considered to be an elite, highly competitive specialty, with little room for failure. Candidates and trainees tend to cultivate a certain urbane and confident style, and the bottleneck at ST1 can feel rather intense. The majority of...Ocular Melanoma UK launches Ocular Melanoma October to shine a light on rare eye cancer
Ocular Melanoma UK (OMUK) the nation’s only charity dedicated exclusively to supporting those affected by ocular melanoma, today launched Ocular Melanoma October – a nationwide campaign highlighting the realities of living with this rare, life-threatening and often misunderstood cancer. Each...The art of giving generous grains
On the drive home, after a long day of eye screening patients in homeless shelters, I would pass through the boroughs, towns and villages of east London. Stopping at the soup kitchen, I would meet Christian with heavy cataracts, and...
Outcomes of ‘treat and extend’ for neovascular AMD
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...
PRN Ranibizumab verses continuous aflibercept in UK clinical practice
This was a multicentre (21 UK hospitals), national EMR study on treatment naïve nAMD eyes, undergoing predominantly as needed (PRN) Ranibizumab or continuous (fixed or treat and extend - (F/TE)) Aflibercept (Af). The primary outcome was change in vision at...
